PTAB Precedential Decision: Compelling Merits Assessment Not at Play Unless Fintiv Factors 1-5 Favor Discretionary Denial

April 7, 2023

Reading Time : 3 min

USPTO Director Katherine Vidal recently issued a precedential decision making clear that the PTAB must first determine whether Fintiv factors 1-5 favor discretionary denial of a petition before considering whether the unpatentability challenge satisfies the compelling-merits standard. This decision further clarifies certain instructions set forth in a June 21, 2022, USPTO Memorandum titled “Interim Procedure for Discretionary Denials in AIA Post-Grant Proceeding with Parallel District Court Litigation” (“Guidance Memo”).

In this case, the Board instituted inter partes review of a patent disclosing a distributed antenna system that assigns subsets of radio resources. In its decision, the Board declined to exercise its discretion under 35 U.S.C. § 314(a) to deny institution. The Board explained that its refusal was based on the petition satisfying the compelling-merits standard for institution. This consideration is reflected in Fintiv factor 6. To support its determination, the Board pointed to the analysis earlier in its decision regarding each of the petitioner’s asserted grounds. The Board did not address any of the other Fintiv factors, relying on an instruction in the Guidance Memo stating that when the PTAB “determines that the information presented at the institution stage presents a compelling unpatentability challenge, that determination alone demonstrates that the PTAB should not discretionarily deny institution under Fintiv.” The Director then ordered sua sponte review of the Board’s institution decision.

Director review was initiated to address how the Board arrived at its compelling-merits conclusion and the sufficiency of its reasoning. To begin, the Director recognized that the Guidance Memo’s instruction could be read to allow the PTAB to substitute a compelling-merits determination for a Fintiv analysis. But, as the Director explained, that was not her intention. Rather, the intended procedure was for the PTAB to first analyze Fintiv factors 1-5 before considering whether the petition meets the compelling-merits standard. The Director clarified that the PTAB shall apply the compelling-merits standard if its analysis of the other Fintiv factors favor discretionary denial. Here, the Board had skipped the first five factors altogether.

Citing her October 4, 2022, precedential OpenSky decision (summarized here), the Director reiterated that the compelling-merits standard is higher than the reasonable likelihood standard for IPR institution, and the PTAB must provide sufficient reasoning for its determination. The Board in this case had merely pointed to its analysis under the lower institution threshold to demonstrate that the petition had satisfied the compelling-merits standard. The Director found that to be insufficient. Therefore, she vacated the Board’s institution decision and remanded the proceeding for the Board to revisit its Fintiv analysis and reasoning in view of the Director’s guidance.

On remand, the Board updated its institution decision to include a 25-page analysis of its findings with respect to each of the Fintiv factors. The Board began by explaining that factor 1 was neutral while factors 2-5 favored or somewhat favored discretionary denial. Because the Board found that the first five Fintiv factors favored denial, it then assessed whether the petition met the compelling-merits requirement for institution. In its assessment, the Board explained that the petitioner had set forth a compelling unpatentability challenge to claim 1 under Ground 1. The Board detailed how it determined limitation-by-limitation that it was highly likely that the petitioner would prevail in its challenge.

Practice Tips: The Director has made clear that the PTAB shall not apply the compelling-merits standard for institution if Fintiv factors 1-5 do not favor discretionary denial. And if the PTAB reaches the compelling-merits question, it must then sufficiently explain the reasoning for its determination. Petitioners should expect to receive a more thorough assessment of all six factors in institution decisions as panels comply with the Director’s Guidance Memo and recent precedential decisions. This case serves as a reminder that Fintiv remains an important consideration in whether panels institute review, and parties should consider carefully the extent to which they argue the Fintiv factors in their papers moving forward.

CommScope Technologies LLC et al. v. Dali Wireless, Inc., IPR2022-01242, Paper 23 (PTAB Feb. 27, 2023); CommScope Technologies LLC et al v. Dali Wireless, Inc., IPR2022-01242, Paper 24 (PTAB Mar. 17, 2023).

Share This Insight

Previous Entries

IP Newsflash

May 30, 2025

A district court recently dismissed a patent infringement complaint for improper venue under 28 U.S.C. § 1400(b), finding that the storage and distribution of products from an Amazon warehouse was not sufficient to establish that warehouse as a regular and established place of business in the district.

...

Read More

IP Newsflash

May 27, 2025

The Federal Circuit affirmed a District of Delaware finding of non-infringement in an ANDA litigation due to the patentee’s clear and unmistakable disavowal of claim scope during prosecution. Specifically, the court held that statements made during prosecution of a parent application before the asserted claims were allowed amounted to a prosecution disclaimer that extended to subsequent patents in the family. In reaching this conclusion, the court rejected an attempt by the patentee to resurrect the claim scope through a unilateral, self-serving statement made in later applications in the family.

...

Read More

IP Newsflash

May 13, 2025

The Federal Circuit recently affirmed a district court’s holding that patent term extension (PTE) for a reissued patent was properly based on the issue date of the original patent and not that of the reissued patent. The Federal Circuit concluded that, where both the original and reissued patents claimed a drug product under regulatory review, using the issue date of the original patent to calculate PTE comports with both the purpose of the Hatch-Waxman Act and the related statutory context.

...

Read More

IP Newsflash

May 12, 2025

The Patent Trial and Appeal Board recently declined to institute a petition for IPR that was filed on the same day that the petitioner filed another petition challenging the same claims of the same patent. The board was not persuaded by petitioner’s arguments that a second petition was needed due to alleged claim construction issues or the number, length or scope differences of the challenged claims.

...

Read More

IP Newsflash

May 9, 2025

The USPTO Director vacated the board’s decision to institute inter partes review based on an erroneous application of the Fintiv factors. Specifically, the Director found that the board placed too much emphasis on Petitioner’s Sotera stipulation, and not enough emphasis on the investment in the parallel litigation. Weighing the factors as a whole, the Director determined that institution should be denied.

...

Read More

IP Newsflash

May 9, 2025

In an institution decision following the USPTO’s withdrawal of its Fintiv Memo, the board addressed discretionary denial of an IPR under Fintiv in view of a parallel ITC investigation. The board noted it would not consider the now-rescinded June 2022 memo from then-director Vidal which instructed that the PTAB would not deny institution of an IPR or PGR under Fintiv when the request is based on a parallel ITC investigation. The board conducted a Fintiv analysis in view of the ITC investigation, but ultimately determined that discretionary denial was not warranted in this particular situation.

...

Read More

IP Newsflash

April 23, 2025

The Federal Circuit recently refused to apply collateral estoppel to claims of a patent asserted in district court litigation based on a Patent Trial and Appeal Board (PTAB) decision finding similar claims from the same patent unpatentable because the PTAB applied a lower burden of proof than what is required to invalidate claims in district court.

...

Read More

IP Newsflash

April 7, 2025

The Central District of California denied a defendant’s motion to dismiss or transfer plaintiff’s first-filed declaratory judgment action based on defendant’s later-filed patent infringement suit in Wisconsin.  Though suit was seemingly imminent when defendant advised plaintiff it might be infringing defendant’s patents, plaintiff responded by requesting a licensing agreement in lieu of litigation. The court found that plaintiff’s action was not anticipatory forum-shopping litigation because plaintiff only filed suit after defendant neglected to respond to its licensing offer.

...

Read More

© 2025 Akin Gump Strauss Hauer & Feld LLP. All rights reserved. Attorney advertising. This document is distributed for informational use only; it does not constitute legal advice and should not be used as such. Prior results do not guarantee a similar outcome. Akin is the practicing name of Akin Gump LLP, a New York limited liability partnership authorized and regulated by the Solicitors Regulation Authority under number 267321. A list of the partners is available for inspection at Eighth Floor, Ten Bishops Square, London E1 6EG. For more information about Akin Gump LLP, Akin Gump Strauss Hauer & Feld LLP and other associated entities under which the Akin Gump network operates worldwide, please see our Legal Notices page.